Michael Lee Brooks - Feb 23, 2023 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role: Chief Operating Officer
Signature: /s/ Sara Epstein, Attorney-in-Fact
Stock symbol: SYNH
Transactions as of: Feb 23, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/24/2023, 04:08 PM
Previous filing: Feb 17, 2023
Next filing: May 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SYNH	Class A Common Stock	Award	$0	+738	+0.61%	$0.00	121K	Feb 23, 2023	Direct	F1
transaction	SYNH	Class A Common Stock	Award	$0	+2.08K	+1.72%	$0.00	123K	Feb 23, 2023	Direct	F2
holding	SYNH	Class A Common Stock						7.03K	Feb 23, 2023	By spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full on the date on which the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.
F2	Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2024, subject to continued employment.

Content

Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full on the date on which the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.

Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2024, subject to continued employment.